Sierra Oncology Q4 EPS $(1.67) Down From $(1.37) YoY
Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.67) per share. This is a 21.9 percent decrease over losses of $(1.37) per share from the same period last year.
HC Wainwright & Co. Maintains Buy on Sierra Oncology, Raises Price Target to $51
HC Wainwright & Co. maintains Sierra Oncology (NASDAQ:SRRA) with a Buy and raises the price target from $35 to $51.
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Reneo Pharmaceuticals (NASDAQ:RPHM) shares increased by 6.4% to $6.82 during Wednesday's after-market session. The company's market cap stands at $166.5 million.
32 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.
Mid-Afternoon Market Update: Dow Turns Higher; General Electric Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.12% to 34,405.65 while the NASDAQ fell 1.19% to 13,690.05. The S&P also fell, dropping, 0.57% to 4,384.81.
Mid-Day Market Update: Nasdaq Tumbles 300 Points; Sierra Oncology Shares Jump
Midway through trading Tuesday, the Dow traded down 1.15% to 33,968.17 while the NASDAQ fell 2.20% to 13,549.98. The S&P also fell, dropping, 1.68% to 4,336.24.
Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views
Following the market opening Tuesday, the Dow traded down 1.79% to 33,748.82 while the NASDAQ fell 2.56% to 13,499.97. The S&P also fell, dropping, 2.59% to 13,496.29.
Sierra Oncology Secures Debt Facility Of Up To $125M With Oxford Finance To Support Momelotinib Development
Sierra Oncology Inc (NASDAQ: SRRA) has